PTK2 and breast cancer: Even though the positive association between genetically predicted IGF-1 concentrations and BC risk seems to be restricted to ER+ tumors53, other studies reported that, at the biological level, IGF-1/IGF-1R-FAK-YAP network cascade triggers the growth potential of triple-negative BC cells, potentially contributing to the progression of the aggressive TNBC subtype54,55.